Publications by authors named "Lujia Sun"

Claim this Profile
A
Antisera and antivirals targeting the conserved domains in SARS-CoV-2 S2 subunit are effective against ACE2-using MERSr-CoVs with spillover potential.
Lujia Sun, Bianying Feng, Zezhong Liu, Jingqi Chen, Xiangwen Hao

Virol Sin· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted early fusion intermediates in the spike of ACE2-utilising bat coronavirus unveil broad-spectrum antiviral mechanisms.
Lujia Sun, Zhimin Liu, Lixiao Xing, Xiaoxing Liang, Lu Lu, Lei Sun

Clin Transl Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel.
Han Zhang, Shuxin Shi, Lujia Sun, Shuangqu Li, Yan Zhang

Curr Res Microb Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decabromodiphenyl ethane exposure-mediated mitochondrial dysfunction drives oxeiptosis in placental trophoblasts and induces fetal growth restriction.
Lumei Xie, Hongli Liu, Xinyue Hu, Jiacheng Xu, Bingdi Chao, Lujia Sun, Luming Sun

J Environ Manage· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
Lixiao Xing, Zhimin Liu, Xinling Wang, Qianying Liu, Wei Xu, Lujia Sun, Lei Sun

Cell· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation.
Lujia Sun, Bo Chen, Xianbo Liu, Yun Zhu, Guangxu Zhang

Curr Res Microb Sci· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination.
Lujia Sun, Qiuhong Man, Hui Zhang, Shuai Xia, Lu Lu

J Infect· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen.
Xinling Wang, Lujia Sun, Zezhong Liu, Lixiao Xing, Yun Zhu

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines.
Pan Huang, Lujia Sun, Jinhao Li, Qingyi Wu, Nima Rezaei

Cell Discov· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mobile Health in China: Well Integrated or a New Divide?
Lujia Sun, Martin Buijsen

Camb Q Healthc Ethics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multitargeted drug design strategy for discovery of short-peptide-based HIV-1 entry inhibitors with high potency.
Chao Wang, Huan Wang, Xinling Wang, Lujia Sun, Qian Wang

Eur J Med Chem· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Artificial Peptide-Based Bifunctional HIV-1 Entry Inhibitor That Interferes with Viral Glycoprotein-41 Six-Helix Bundle Formation and Antagonizes CCR5 on the Host Cell Membrane.
Chao Wang, Qing Li, Lujia Sun, Xinling Wang, Huan Wang

Viruses· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential recombination between SARS-CoV-2 and MERS-CoV: calls for the development of Pan-CoV vaccines.
Qiao Wang, Lujia Sun, Shibo Jiang

Signal Transduct Target Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: Wearing nasal masks where facial masks cannot be used.
Zijie Lin, Lujia Sun, Liliang Li, Shibo Jiang

J Med Virol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein.
Songyi Xue, Xinling Wang, Lei Wang, Wei Xu, Shuai Xia, Lujia Sun, Xingmin Sun

Cell Discov· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative mass spectrometry analysis of N-glycans from the glycoproteins of eight allergy-inducing plants.
Yu Lu, Lujia Sun, Cheng Li, Xiaoqin Wang, Wenqing Li

Food Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Online LC-UV-ESI-MS/MS Comparative Analysis of Changes in Goat Colostrum /-Glycopatterns at Different Parities.
Yu Lu, Wanjun Jin, Yuerong Yang, Yue Jia, Lujia Sun

J Agric Food Chem· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass Spectrometry Analysis of Changes in Human Milk /-Glycopatterns at Different Lactation Stages.
Yu Lu, Jie Liu, Yue Jia, Yuerong Yang, Qinghui Chen, Lujia Sun

J Agric Food Chem· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis